Boddy AV - Search Results

1

Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry.

Veal GJ, Errington J, Sludden J, Griffin MJ, Price L, Parry A, Hale J, Pearson AD, Boddy AV; UKCCSG Pharmacology Working Group. Veal GJ, et al. Among authors: boddy av. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 5;795(2):237-43. doi: 10.1016/s1570-0232(03)00573-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 14522028

2

Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.

Veal GJ, Cole M, Errington J, Parry A, Hale J, Pearson AD, Howe K, Chisholm JC, Beane C, Brennan B, Waters F, Glaser A, Hemsworth S, McDowell H, Wright Y, Pritchard-Jones K, Pinkerton R, Jenner G, Nicholson J, Elsworth AM, Boddy AV; Kingdom Children's Cancer Study Group Pharmacology Working Group. Veal GJ, et al. Among authors: boddy av. Clin Cancer Res. 2005 Aug 15;11(16):5893-9. doi: 10.1158/1078-0432.CCR-04-2546. Clin Cancer Res. 2005. PMID: 16115931 Clinical Trial.

3

Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.

Hill CR, Cole M, Errington J, Malik G, Boddy AV, Veal GJ. Hill CR, et al. Among authors: boddy av. Clin Pharmacokinet. 2014 Aug;53(8):741-51. doi: 10.1007/s40262-014-0153-2. Clin Pharmacokinet. 2014. PMID: 24968986 Free PMC article.

4

Pharmacokinetics and pharmacogenetics of 13-cis-retinoic acid in the treatment of neuroblastoma.

Veal G, Rowbotham S, Boddy A. Veal G, et al. Therapie. 2007 Mar-Apr;62(2):91-3. doi: 10.2515/therapie:2007020. Epub 2007 Jun 21. Therapie. 2007. PMID: 17582307

5

Dosing of cancer patients with low or absent renal function.

Boddy A, Griffin M, Knowles S, Persic M, Scott I, Errington J, Veal G. Boddy A, et al. Therapie. 2007 Mar-Apr;62(2):117-20. doi: 10.2515/therapie:2007022. Epub 2007 Jun 21. Therapie. 2007. PMID: 17582312 No abstract available.

6

Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.

Veal GJ, Errington J, Redfern CP, Pearson AD, Boddy AV. Veal GJ, et al. Among authors: boddy av. Biochem Pharmacol. 2002 Jan 15;63(2):207-15. doi: 10.1016/s0006-2952(01)00844-9. Biochem Pharmacol. 2002. PMID: 11841795

7

Chemotherapy individualization.

Veal GJ, Coulthard SA, Boddy AV. Veal GJ, et al. Among authors: boddy av. Invest New Drugs. 2003 May;21(2):149-56. doi: 10.1023/a:1023517311879. Invest New Drugs. 2003. PMID: 12889736 Review.

8

Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do we really know?

Cole M, Boddy AV, Kearns P, Teh KH, Price L, Parry A, Pearson AD, Veal GJ; UKCCSG Pharmacology group. Cole M, et al. Among authors: boddy av. Pediatr Blood Cancer. 2006 Jun;46(7):723-7. doi: 10.1002/pbc.20463. Pediatr Blood Cancer. 2006. PMID: 16007598

9

Biliary excretion of etoposide in children with cancer.

Veal GJ, Errington J, Thomas HD, Boddy AV, Lowis S. Veal GJ, et al. Among authors: boddy av. Cancer Chemother Pharmacol. 2006 Sep;58(3):415-7. doi: 10.1007/s00280-005-0180-7. Epub 2006 Jan 18. Cancer Chemother Pharmacol. 2006. PMID: 16418874

10

Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia.

Boddy AV, Sludden J, Griffin MJ, Garner C, Kendrick J, Mistry P, Dutreix C, Newell DR, O'Brien SG. Boddy AV, et al. Clin Cancer Res. 2007 Jul 15;13(14):4164-9. doi: 10.1158/1078-0432.CCR-06-2179. Clin Cancer Res. 2007. PMID: 17634544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page